Target intelligence / Profile preview

Cytochrome b-245 beta chain (NOX2) (NOX2)

Target
NOX2
Molecular classification
Enzyme, Oxidoreductase, NADPH oxidase, Heme-binding protein, Transmembrane protein
01

Overview

Cytochrome b-245 beta chain, commonly known as NOX2 or gp91phox, is the catalytic, membrane-spanning subunit of the phagocyte NADPH oxidase complex [1, 4, 6]. Its primary biological function is to transfer electrons from NADPH to molecular oxygen, generating superoxide radicals and other reactive oxygen species (ROS) essential for the microbicidal activity of phagocytes like neutrophils and macrophages [5, 9, 10]. Mutations in the CYBB gene, which encodes this protein, lead to X-linked Chronic Granulomatous Disease (CGD), a condition characterized by a severely compromised immune system and recurrent life-threatening infections [1, 5, 14]. Conversely, excessive NOX2 activity and the resulting oxidative stress are implicated in the pathogenesis of various chronic conditions, including atherosclerosis, hypertension, neurodegenerative diseases, and chronic inflammation [3, 6, 9]. Consequently, NOX2 has emerged as a significant therapeutic target, with small-molecule inhibitors like GSK2795039 being developed to mitigate oxidative damage in these diseases [3, 7, 9]. However, therapeutic inhibition of NOX2 carries the risk of inducing a transient CGD-like state, potentially increasing patient susceptibility to infections [3, 10].

Other names
CYBBgp91phoxgp91-phoxp91-PHOXNADPH oxidase 2Cytochrome b-245 heavy chainCytochrome b558 subunit betaSuperoxide-generating NADPH oxidase heavy chain subunitHeme-binding membrane glycoprotein gp91phox
02

Mechanism of action

Inhibition of the NADPH oxidase complex to prevent the transfer of electrons from NADPH to molecular oxygen, thereby reducing the production of superoxide and other reactive oxygen species (ROS).

03

Biological functions

Immune responseReactive oxygen species generationSuperoxide productionPhagocytosisMicrobicidal activityCell signalingInflammation regulation
04

Disease associations

Chronic granulomatous diseaseInflammationCardiovascular diseaseNeurodegenerative diseaseCancerInfectionSepsis
05

Safety considerations

Increased susceptibility to infectionImmunosuppressionImpaired microbicidal activityPotential for chronic granulomatous disease-like symptomsImpaired wound healing
06

Interacting drugs

GSK2795039

5 more in the full profile.

07

Biomarkers

Superoxide productionDihydrorhodamine 123 assayNitroblue tetrazolium testSerum NOX2 levelsPhagocytic respiratory burst activity

Beyond the preview

Go deeper on Cytochrome b-245 beta chain (NOX2) (NOX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome b-245 beta chain (NOX2) (NOX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call